Dr Kevin Khalili Pain Relief Cream

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as arthritis, simple backache, muscle strains, bruises, and joint sprains.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The tube should be shaken prior to each use, and the product must be used only as directed. For adults and children over 12 years of age, the recommended application is to the affected areas not more than twice daily. The product should be massaged into the painful areas until it is thoroughly absorbed into the skin.

It is essential to wash hands with soap and water after each application to prevent unintentional contact with other areas of the body or surfaces. For children aged 12 years or younger, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

Tight bandaging or application with heat is not recommended, as it may lead to adverse effects. Contact with eyes, wounds, contact lenses, damaged skin, or mucous membranes should be strictly avoided to prevent irritation or injury. Additionally, the use of this product in hot tubs or steam rooms is contraindicated due to the potential for increased absorption and associated risks.

Warnings and Precautions

For external use only. It is imperative that the product is utilized strictly as directed to ensure safety and efficacy. Healthcare professionals should advise patients to avoid contact with the eyes, open wounds, contact lenses, damaged skin, or mucous membranes to prevent adverse reactions. Additionally, patients should be cautioned against tightly bandaging the area of application or using the product in conjunction with heat sources. The use of hot tubs or steam rooms should also be avoided during treatment.

Patients must be instructed to discontinue use and consult a healthcare provider if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve only to recur within a few days. The development of skin irritation or redness is another critical indicator that warrants immediate medical consultation.

In the event of accidental ingestion, it is essential to seek emergency medical assistance or contact poison control without delay to mitigate potential health risks.

Side Effects

Patients should be aware that this product is for external use only. It is essential to use the product strictly as directed and to avoid contact with the eyes, wounds, contact lenses, damaged skin, or mucous membranes. Patients are advised not to bandage the area tightly or use heat in conjunction with the product. Additionally, exposure to hot tubs or steam rooms should be avoided during use.

In the event that the condition worsens, symptoms persist for more than seven days, or if symptoms clear up and then recur within a few days, patients should discontinue use and consult a healthcare professional. The development of skin irritation or redness also warrants stopping use and seeking medical advice.

For pregnant or breastfeeding individuals, it is recommended to consult a doctor prior to use. Furthermore, this product should be kept out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or poison control should be contacted.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Dr Kevin Khalili Pain Relief Cream (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. For adolescents and adults over 12 years, the recommended application is to the affected areas no more than twice daily.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with the use of this drug during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and therefore, caution is advised.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact poison control. Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage.

Healthcare professionals should be vigilant for symptoms that may arise from an overdose, although specific symptoms are not detailed in the provided information. The management of overdosage should be guided by clinical judgment and may involve supportive care and symptomatic treatment as necessary.

It is essential for healthcare providers to remain informed about the appropriate protocols for managing overdosage cases, ensuring that patients receive timely and effective care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact poison control in the event of accidental ingestion. Patients should be instructed to stop using the product and consult their doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, patients should also stop use and seek medical advice.

It is important for healthcare providers to emphasize the necessity of using the product only as directed. Patients should be cautioned to avoid contact with eyes, wounds, contact lenses, damaged skin, or mucous membranes. They should also be informed not to bandage the area tightly or use the product in conjunction with heat. Furthermore, patients should be advised to avoid hot tubs and steam rooms while using the product. If any skin irritation or redness develops, patients should discontinue use and consult their healthcare provider.

Storage and Handling

The product is supplied in a tube format. It should be stored at a temperature range of 21° to 24°C (69° to 78°F). Prior to each use, the tube must be shaken to ensure proper consistency. It is essential to wash hands with soap and water after each application. The product should be discarded after opening to maintain safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than twice daily for adults and children over 12 years to the affected areas. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dr Kevin Khalili Pain Relief Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)